
FDA approves new drug to slow Alzheimer’s disease
A new Alzheimer’s drug has proven to be highly successful in directly preventing the disease. Photo: File Washington: The Food and Drug Administration (FDA), the US drug approval agency, has approved the first drug to slow Alzheimer’s disease. Although it is an expensive drug with an annual cost of $26,000. This drug called ‘Lacombe’ is…